Phosphatidylethanolamine (PtdEtn) N-methyltransferase activities were studied in rat heart sarcolemmal and sarcoplasmic reticular fractions after a single intraperitoneal injection of isoproterenol (0.5-5.0 mg/kg). Three active sites (I, II, and III) for PtdEtn N-methylation were assayed by measurement of [3H]methyl group incorporation from 0.055, 10, and 150 ,uM S-adenosyl-L-[methyl-3H]methionine into membrane PtdEtn molecules. Total methylation activity for catalytic site I of both sarcolemma and sarcoplasmic reticulum was stimulated within 2 minutes by isoproterenol in a dose-dependent manner. Although the increased methyltransferase activity in sarcoplasmic reticulum was normalized at 10 minutes, the enzyme activity in sarcolemma was normalized at 5 minutes but was again increased at 10-30 minutes after isoproterenol injection. No changes in response to isoproterenol were seen for site II and III N-methylation activities in either membrane. Individual N-methylated phospholipids (phosphatidyl-N-monomethylethanolamine, phosphatidyl-N, N-dimethylethanolamine, and phosphatidylcholine), which specifically formed at each site, showed similar behavior. Pretreatment of the animals with a /3-blocking drug, atenolol, for 2 days prevented the isoproterenol-induced changes in hemodynamic parameters and sarcolemmal methylation without affecting the enhanced methylation activities in sarcoplasmic reticulum. In vitro addition of cyclic AMPdependent protein kinase (catalytic subunit) plus Mg-ATP enhanced methyltransferase activities in sarcolemma and sarcoplasmic reticulum from control hearts by 2.7and 2.3-fold, respectively; however, under the same in vitro conditions, only about 20% activation was seen in both subcellular membranes isolated from the heart of isoproterenol-injected animals. These results suggest that both cardiac sarcolemmal and sarcoplasmic reticular methyltransferase activities are rapidly activated by isoproterenol while the underlying mechanism may be different. This study also indicates that cyclic AMP-dependent protein kinase catalyzed phosphorylation can stimulate the methyltransferase system in both sarcolemmal and sarcoplasmic reticular membranes. (Circulation Research 1990;66:28-36) T he phospholipid composition of the membrane is known to play an important role in a variety of functions oI the myocardial cell and to be regulated by an integrated network of biosynthetic reactions. One of these reactions is the conversion of phosphatidylethanolamine (PtdEtn) into phosphatidylcholine (PtdCho) by three successive N-terminal methylations in which S-adenosyl-
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Yuji Taira, Vincenzo Panagia, Kanhaiya R. Shah, Robert E. Beamish, and Naranjan S. Dhalla Phosphatidylethanolamine (PtdEtn) N-methyltransferase activities were studied in rat heart sarcolemmal and sarcoplasmic reticular fractions after a single intraperitoneal injection of isoproterenol (0.5-5.0 mg/kg). Three active sites (I, II, and III) for PtdEtn N-methylation were assayed by measurement of [3H]methyl group incorporation from 0.055, 10, and 150 ,uM S-adenosyl-L-[methyl-3H]methionine into membrane PtdEtn molecules. Total methylation activity for catalytic site I of both sarcolemma and sarcoplasmic reticulum was stimulated within 2 minutes by isoproterenol in a dose-dependent manner. Although the increased methyltransferase activity in sarcoplasmic reticulum was normalized at 10 minutes, the enzyme activity in sarcolemma was normalized at 5 minutes but was again increased at 10-30 minutes after isoproterenol injection. No changes in response to isoproterenol were seen for site II and III N-methylation activities in either membrane. Individual N-methylated phospholipids (phosphatidyl-N-monomethylethanolamine, phosphatidyl-N, N-dimethylethanolamine, and phosphatidylcholine), which specifically formed at each site, showed similar behavior. Pretreatment of the animals with a /3-blocking drug, atenolol, for 2 days prevented the isoproterenol-induced changes in hemodynamic parameters and sarcolemmal methylation without affecting the enhanced methylation activities in sarcoplasmic reticulum. In vitro addition of cyclic AMPdependent protein kinase (catalytic subunit) plus Mg-ATP enhanced methyltransferase activities in sarcolemma and sarcoplasmic reticulum from control hearts by 2.7and 2.3-fold, respectively; however, under the same in vitro conditions, only about 20% activation was seen in both subcellular membranes isolated from the heart of isoproterenol-injected animals. These results suggest that both cardiac sarcolemmal and sarcoplasmic reticular methyltransferase activities are rapidly activated by isoproterenol while the underlying mechanism may be different. This study also indicates that cyclic AMP-dependent protein kinase catalyzed phosphorylation can stimulate the methyltransferase system in both sarcolemmal and sarcoplasmic reticular membranes. (Circulation Research 1990;66: [28] [29] [30] [31] [32] [33] [34] [35] [36] T he phospholipid composition of the membrane is known to play an important role in a variety of functions oI the myocardial cell and to be regulated by an integrated network of biosynthetic reactions. One of these reactions is the conversion of phosphatidylethanolamine (PtdEtn) into phosphatidylcholine (PtdCho) by three successive N-terminal methylations in which S-adenosyl-L-methionine (AdoMet) acts as a physiological methyl donor. Previously we have identified three catalytic sites of methyltransferase(s), which convert PtdEtn to PtdCho in cardiac subcellular membranes in a stepwise manner.1 Isoproterenol, a potent cardiac stimulant, has been shown to increase PtdEtn Nmethylation in various preparations under in vitro conditions.2-4 Recently, Okumura et a15 reported changes in PtdEtn N-methylation activity in sarcolemmal (SL) and sarcoplasmic reticular (SR) membranes in catecholamine-induced cardiomyopathy produced by 40 mg/kg isoproterenol. Since enzymatic Nmethylation of intramembranal PtdEtn has been shown to influence Ca2+ transport across heart membranes6-8 and membrane fluidity,2'9 it is possible that changes in PtdEtn N-methylation activities of cardiac subcellular organelles may contribute to catecholamine-induced positive inotropic effect. In this study, therefore, we examined the SL and SR PtdEtn N-methylation activities after low doses of isoproterenol in rats. In addition, we investigated whether or not the effects of isoproterenol on phospholipid N-methylation are mediated through ,3adrenergic receptors. Since most of the /3-adrenergic receptor-coupled reactions in the cell involve phosphorylation due to cyclic AMP-dependent protein kinase,10 the action of the catalytic subunit of cyclic AMP-dependent protein kinase was studied on PtdEtn N-methylation in cardiac subcellular membranes.
Materials and Methods

Experimental Animals
Adult male Sprague-Dawley rats weighing 200-250 g were used in this study. Animals were killed 0.5, 1, 2, 5, 10, 20, and 30 minutes after an intraperitoneal injection of isoproterenol (5 mg/kg body wt). Control animals received a similar injection of saline solution. After decapitation, the heart was rapidly excised, atria and any large vessels were carefully trimmed, and the ventricular muscle was processed for the isolation of subcellular membranes.
Isolation of Cardiac Subcellular Fractions
Purified SL membranes were prepared from pools of two or three hearts by the hypotonic shock-LiBr treatment method.'1 It has been previously demonstrated that the SL preparation containing basement membrane obtained by this procedure is of cardiac cell membrane origin, possesses minimal contamination by other subcellular organelles, and is devoid of endothelial cell membranes.1"-14 In some experiments, the sucrose gradients procedure described by Pitts'5 was also employed for the isolation of SL. Sarcoplasmic reticular fragments (microsomes) were obtained according to the method described by Sulakhe Hemodynamic Studies Rats were anesthetized with pentobarbital sodium (50 mg/kg i.p.) and assessed hemodynamically according to the method employed by Afzal et al.'9 After intubation of the trachea for adequate ventilation, the right carotid artery was exposed and a microtip pressure transducer (model SPR-249, Millar Instruments, Houston, Texas) was introduced through a proximal arteriotomy. The catheter was advanced carefully through the carotid artery until the tip of the transducer entered the left ventricle. The catheter was then secured in place with a silk ligature tied around the artery and connected to a dynograph recorder (model RSHA, Beckman Instruments, Fullerton, California). Left ventricular pressure, heart rate, and ECG (lead II) were recorded. After 15-20 minutes of stabilization of the animal, isoproterenol was administered intraperitoneally; for control experiments the same amount of saline was injected.
Materials
['H]AdoMet (specific activity 75.7 Ci/mmol) was purchased from Amersham, Oakville, Ontario, Canada. DL-Isoproterenol hydrochloride, phosphatidylcholine, and catalytic subunit of cyclic AMPdependent protein kinase were purchased from Sigma Chemical, St. Louis, Missouri. AdoMet was obtained from RBI, Natick, Massachusetts. PtdEtnMe and PtdEtnMe2 were obtained from Calbiochem-Behring, San Diego, California. Atenolol was obtained from Imperial Chemical Industries, Macclesfield, England. Silica gel 60 F-254 thin-layer chromatography plates were purchased from E. Merck, Darmstadt, FGR. All other reagents were of analytical grade.
Statistics
Results are presented as mean±+SEM. The statistical differences between mean values for two groups were evaluated by Student's t test. For comparison of more than two groups, multiple analysis of variance was carried out, and Duncan's new multiple-range test was used to determine differences between the means within the population.20 
Results
General Characteristics of Subcellular Membranes
The protein yields of SL11,15 and SR16 preparations were not significantly altered on treatment of the animals with 5 mg/kg isoproterenol for 30 minutes. Routine examination of the SL and SR membranes from control and isoproterenol-treated animals revealed no significant differences in the purification of various subcellular marker enzymes. Ouabainsensitive Na+,K+-ATPase activity, a well-known marker of the plasma membrane, exhibited about an eightfold to 10-fold increase in purity over homogenate values in SL preparations for the control (14.3 + 0.9 gmol P./mg/hr) and experimental (13.3 ± 0.8 ,gmol PJ/mg/hr) hearts, while ouabain-sensitive Na+K+-ATPase activity in the SR fraction was 60-80% of the homogenate values in both control (1.17±0. 19 ,gmol PJ/mg/hr) and isoproterenoltreated (1.24±0.15 ,umol PJ/mg/hr) groups. K+-EDTA-stimulated ATPase activity was not detectable in the SL and SR fractions employed in this study, which excludes the possibility of myofibrillar contamination. Furthermore, the cytochrome c oxidase activity was similar (about 60% of the 0.38 ±0.05 gmol/mg/min homogenate value) between control and experimental animals in SL and SR fractions. No appreciable azide-sensitive Mg2`-ATPase activity was noticed in SL and SR fractions; this finding indicated that the mitochondrial contamination in these preparations was minimal and comparable in control and experimental samples.
Sarcolemmal and Sarcoplasmic Reticular PtdEtn N-Methylation Activities
The catalytic activities of three sites involved in SL and SR PtdEtn N-methylation were examined at 0.5, 1, 2, 5, 10, 20, and 30 minutes after 5 mg/kg isoproterenol. N-Methylation activity was significantly increased at site I soon after the injection (1 and 2 minutes) in both SL and SR preparations ( Figure 1 ). Although the increased methylation activity in SR returned to normal after 10 minutes, SL methylation activity showed a second increase after 10 minutes (after becoming normal at 5 minutes) and remained at a high level up to 30 minutes ( Figure 1 ). Sites II and III methylation activity showed no difference between control and experimental groups for any of the time points tested in both SL and SR (only a part of the data is given in Table 1 ). Thus, N-methylation changes due to isoproterenol were limited to site I, and the time course of these changes in SL was different from that in SR.
The effect of isoproterenol administration on cardiac N-methylation was examined in SL and SR at different doses (0.5, 1.0, 3.0, and 5.0 mg/kg). Because both SL and SR methylations were stimulated maximally at 2 minutes of isoproterenol injection, this time was used for this experiment. The lowest dose of isoproterenol (0.5 mg/kg) was insufficient to elicit a significant stimulation of methylation, but higher doses showed a dose-dependent increase in both SL and SR preparations ( Figure 2) .
To determine the identity of methylated phospholipids that resulted from the above-mentioned changes in both SL and SR PtdEtn N-methylation at site I, we examined radiolabeled phospholipid components of the PtdEtn N-methyltransferase pathway under optimal conditions for site I. It has been pointed out that the catalytic activity for site I is best assayed at low AdoMet concentrations (less than 1 gM)117 and is manifested by the predominant synthesis of PtdEtnMe, whereas the formation of PtdEtnMe2 and PtdCho is comparatively minimized. In SL membrane ['H1methyl group incorporation into PtdEtnMe was found to be significantly increased at 2 and 20 minutes after isoproterenol injection, whereas ['H]methyl group incorporation into PtdEtnMe in SR membrane was found to be increased at 2 minutes only ( Table 2 ). These changes were parallel with those in total methylation (Table 1 ) and confirmed the occurrence of site I alterations in the N-methylation reaction. From Table 2 it can also be seen that the formation of PtdEtnMe2 and PtdCho was significantly increased when PtdEtnMe production was increased. This may possibly reflect an increased availability of methylated precursors to sites II and III due to isoproterenol-induced activation of site I, which is the rate-limiting step of the methylation process.21 To further characterize the changes in SL and SR PtdEtn N-methylation, we studied kinetics of [3H]methyl group incorporation at site I in the hearts of control rats and 2 minutes after 5 mg/kg isoproterenol injection using different concentrations of [3H]AdoMet as radiolabeled methyl donor (Figures 3  and 4 ). In both membranes, the double reciprocal plots obtained in the concentration range of 0.02-0.33 ,uM [3H]AdoMet were linear and indicated that the apparent affinities for AdoMet were unaltered in isoproterenol-injected hearts, whereas the apparent maximum rate of incorporation (Vma,) values were higher at 2 minutes after injection of isoproterenol in both membranes.
To exclude the possibility that the observed changes in PtdEtn N-methylation were influenced by the isolation procedure used for the preparation of SL, we employed a different method for obtaining the SL membranes. The method described by Pitts15 was used since it provides SL membranes that have been well characterized in terms of PtdEtn N-methylation and are relatively free from contamination by other subcellular organelles.' The results shown in Table 3 confirm that the phospholipid N-methylation activity due to site I was increased in the SL membrane at 2 and 20 minutes after isoproterenol injection.
Effect of Cyclic AMP-Dependent Protein Kinase on
Methyltransferase Activity
To obtain further information regarding the activation of methyltransferase in SL and SR upon injection of isoproterenol, we examined the effect of Mg-ATP plus catalytic subunit of cyclic AMPdependent protein kinase on methylation activity in vitro by use of subcellular membranes from control and 2-minute postisoproterenol hearts. In control hearts, the incubation of subcellular membranes with Mg-ATP plus catalytic subunit of cyclic AMPdependent protein kinase resulted in 2.7and 2.3fold increases of site I methylation reaction in SL and isoproterenol injection on the hemodynamic parameters and methyltransferase activity was then tested.
Atenolol was used because it has no direct effect by itself on the methyltransferase system.22 Ventricular systolic pressure increased soon after isoproterenol injection in control rats, but this increase was abolished by the atenolol pretreatment ( Figure 5A ). Heart rate increased in less than 1 minute after isoproterenol administration in control rats, and the atenolol pretreatment inhibited this increase considerably (Figure 5B) . The rapidly occurring positive chronotropic effect in control animals indicates that the intraperitoneal injection of isoproterenol is readily absorbed and distributed into the circulation, as reported by others.23 Ventricular diastolic pressure showed negligible changes after isoproterenol injection in both control and atenolol-pretreated rats (data not shown). Furthermore, isoproterenol administration induced various forms of ventricular arrhythmias in control rats, but almost no arrhythmia was induced in atenolol- pretreated animals. Table 5 shows the effect of atenolol pretreatment on the stimulation of methyltransferase by isoproterenol in SL and SR membranes. The stimulation of SL site I methyltransferase activity 2 and 20 minutes after isoproterenol administration was inhibited by pretreatment with atenolol (20 mg/kg for 2 days). On the other hand, the increased SR methyltransferase activity 2 minutes after isoproterenol injection was not affected by atenolol pretreatment. As shown in Table 5 , atenolol pretreatment alone did not exhibit any effect on the site I methyltransferase activity in either SL or SR membranes.
Discussion
Conversion of PtdEtn to PtdCho in the membrane is considered to occur through AdoMet-dependent N-methylation catalyzed by membrane-bound methyltransferase(s). Previous findings have indicated that PtdEtn N-methylation may be involved in modification of cardiac subcellular Ca21 transport systems6-8 and thereby in regulation of the contractile performance of the heart. 24 This study shows that methyltransferase activities of both SL and SR membranes were stimulated within 1 minute by the single intraperi- Basal values of methyltransferase activity in absence of any addition were control, 0.55±0.10 (SL) and 1.58±0.12 (SR) pmol
[3H]methyl incorporation/mg/30 min; and isoproterenol (2 minutes after injection), 1 vivo is a new finding, and this observation may be of some physiological relevance with respect to the effect of isoproterenol on heart function and metabolism. In particular, PtdEtnMe has been related to lipid fluidization.2627 Therefore, rapid PtdEtnMe accumulation in the isoproterenol-injected hearts may be associated with an increase in the membrane fluidity, which may contribute to alteration of heart function. Time-related differences occur in the response of the SL and SR methyltransferase system to isoproterenol. In fact, the time course of SR methylation showed only one peak at 2 minutes after isoproterenol injection, whereas that of SL activity showed a second peak after 20 minutes. The biphasic response at the SL level may be due to the release of endogenous catecholamines into the circulation after isoproterenol administration.28 Temporal differences were noticed also in experimental cardiac hypertrophy. 17 This finding suggests that the SL and SR activities may be controlled and regulated independently. We examined this possibility by studying the effect of cyclic AMP-dependent protein kinase on the methyltransferase system, since catecholamines are known to act through cyclic AMP-dependent protein kinasemediated phosphorylation via their interaction with ,f-receptors. 10 The results indicate that the catalytic subunit of cyclic AMP-dependent protein kinase plus Mg-ATP stimulate the methyltransferase activities in control SL and SR by 2.7-fold and 2.3 -fold, respectively. When the effect of the catalytic subunit plus Mg-ATP was tested on cardiac SL and SR fractions isolated from isoproterenol-injected animals, only about 20% activation of methyl incorporation was noted.
These data show that either the methyltransferase activity was not fully stimulated by the isoproterenol treatment in vivo, or the in vivo maximal stimulation was slightly decreased upon isolation of the membranes from the isoproterenol-treated myocardium. Therefore, it is possible that in both subcellular membranes isoproterenol-induced activation of methyltransferase may occur through cyclic AMP-dependent protein kinase-mediated phosphorylation of the enzyme or through phosphorylation of membrane component(s) controlling the methyltransferase system. No significant effect on site II and III methylation by cyclic AMP-dependent protein kinase was observed, a finding that corresponds with the specific stimulation of site I caused by isoproterenol. Methyltransferase phosphorylation by cyclic AMP-dependent protein kinase also has been suggested as a stimulant of enzyme activity in rat liver preparations. 29 To determine whether the isoproterenol-induced increase of methyltransferase is related to 1lreceptors, we tested the effect of atenolol, a wellknown f,-selective antagonist, on the stimulation of methyltransferase activity caused by the isoproterenol injection. Atenolol was selected because 1) preliminary experiments in our laboratory revealed that, unlike other parent drugs, atenolol had no direct effect on the SL and SR methyltransferase activities in vitro22; 2) previous examination of the order of potency of 3-agonists in brain cortex preparations suggests the involvement of a 3,1-adrenergic receptor subtype in the effect of catecholamine on methylation3; and 3) the fl-receptors present in adult rat ventricular myocytes are exclusively of the I31 subtype. 30 Hemodynamic experiments showed that the atenolol pretreatment employed in this study inhibited the isoproterenol-induced increases in ventricular systolic pressure and heart rate, which suggests that the fl-blockade treatment was adequate. The stimulation of methyltransferase by isoproterenol in SL was completely inhibited by atenolol pretreatment at both the 2and 20-minute time points, whereas atenolol could not block the SR methyltransferase stimulation. From this result, it is possible to say that the stimulation of methyltransferase activity by isoproterenol in SL occurred through ,Breceptor-mediated mechanisms. However, it is difficult to explain why the methyltransferase stimulation at the SR level was insensitive to the fl-blockade. We can speculate several reasons for this finding: 1) SR methyltransferase may be more sensitive to catecholamine than the SL enzyme, and thus, the amount of atenolol used was not sufficient to block the isoproterenol-induced stimulation; 2) catecholamine may enter the cell as such31 and stimulate methyltransferase directly in SR; or 3) there may be some presently unknown mechanism other than P3receptors that stimulate the methylation in SR. This does not exclude the occurrence of cyclic AMP effects on the SR as, for instance, the phosphorylation of phospholamban molecules by cyclic AMPdependent protein kinase.32 Nonetheless, the present results suggest the existence of different regulatory systems for methyltransferase(s) in cardiac SL and SR. The different sensitivity of the methyltransferase system to fl-antagonist has been reported also in astrocytoma cells,33 in which isoproterenol-dependent stimulation of methylation in uninfected cells was blocked by fl-antagonist, while the isoproterenoldependent decrease of methylation in infected cells was not blocked by fl-antagonist. In this regard, it should be mentioned that catecholamine-insensitive methyltransferase has been reported in rabbit aortic smooth muscle cells.34
Ca2' pump activities in both SL and SR have been shown to be stimulated upon methylation of the membranes.6,7 Since the Ca2' pump has a significant role in regulation of the cytosolic calcium concentration as well as cardiac contractility, enhanced methylation activities in both SL and SR by isoproterenol can be seen to affect the cardiac function through changes in Ca2' pump activity in both membranes.
Furthermore, it has been proposed that the number of f-receptor binding sites is increased upon methylation of the cardiac membranes under in vitro conditions.35,36 Therefore, it is possible that the enhanced methyltransferase activity by isoproterenol in SL may increase the number of fl-receptors and augment the effect of catecholamines on the cardiac membranes. Such a view does not mean to undermine the cyclic AMP-mediated phosphorylation effects of catecholamines, and in fact both these mechanisms may be complementary to each other.
